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induced or spontaneous VFNT throughoul tho duration of the study. Mean 
flu was 135 rod, (Range 2-33 me,), ,~Imsing data I~low. 
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gem UPS and !CDs are ctintcalty corepatiblo However, r~refu! mlra,opera. 
lead placement and ~ intera~ion l~Sltng iS cnt~t  in ~e 
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We explored the ~%",~,s  that ~ m ~  c'~rdmvede~/de~l~,ator 
IICD) imlp~anta~on rate amoeg pts w~h ventncu~r ~rdm or fd=n~ 
vanes betwee~ regzons Of ff'~e comltW. The pmpoflmns of ICD |replants among 
3633 no~n-randermzed AVID mgistW pls were compmed among Itre ~ 
(NE), I~d-Allant¢ (MA). Southeast (SE). Midwest (MW). CentregMmmt~n 
(CM), and Pacific (P) mg~ns S~es near geogrepi~ l~danes  were ago- 
cared to aoftmve balanced popu~bon s=ze among ~ .  TemporaZ changes 
were measured by computing It, re ICD m~planlation rate eve~/6 monms be- 
ginning with Januaw, 1993. Mu~lwanate Io~ mgm"=,smn was used to test 
lm the rarefaction bet~ieen re.on ax~l uther patenbal covanatea. F~.,~er ICDs 
were m~amed in Ihe MA ~ (NE 46%, MA 34%, SE 43%, MW 4Po, CM 
54%,, P 47%; k ~ on 5 d.f.: p < 0.001). MOr'J ICDs were im!~ m men 
(45% vs 40%. p < 0.007) and in pts <65 yrs (46% vs 42% p < 0.01). PI~ 
fee4or-sen~e insurance, with or ~ Me~,  were mere hkely to 
recewe an ICD ~tan those w4hout foe-for-sennce msurar.,¢e (47% vs 41%, p 
< 0.001). Wnh moeasmg madret release of FDA ~ nom'horacotomy 
(NT1L) ICDs, the median sen~-annual in~ rate rose trem 36% before 
April, 1995 to 53% after. Muft~vanate analy~s revealed ~ age, gendec 
tee-for-serwce insurance, avadal~lity of NTL ICDs, and regmn of me country 
(MA) were all Independem predatOrS Of ICD tmlptantation Thus. even after 
a~- lm 9 tor age, ~r .  r r ~  type, and avadal~tffy of NTL ICDs. ICD 
,mptantatto~ ,ate was tower m MA 
Cor~us~on: ICDs were tess often u~kzed =n the MA regzon The regzonal 
~fference cannot be explained by the age and gender distnbu~on of the 
ipoputat~n, insurance type. or the avaitat~tity ofNTL ICDs. 
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Background: The imptantabte cardioverter defibnllafor (ICD) is effechve in 
aborting sudden ca~iac death (SCD). Despite pharmacoiogK:al therapy. 
prevention of SCD remains to be a ther'~oeutic dilemma in patients w~th 
hyped~phio c~rdiomyopathy (HCM). Although ICDs l~ve been used w~th 
increasing frequency, clinical outcome of this practice in HCM pts is unknown. 
Methods: Outcome following ICD implantation was assessed in 21 pts 
(F/M = 6115. age = 39 ± 17 yrs): f0 recewed an ICD for pnmary (group A) 
and 11 for secondaw prevention (group B) of SCD. 
Results: Of the 21 implants. 5 (24%) were ep~cardial nd 16 (76%) were 
transvenous (7 active can. 1 subcutaneous patch); the defihrillation threshold 
(OFT) was 15 ± 3 J and 12 + 5 J. respectively (p = ns). Tranvenous 
=mplantation was unsuccessful resulting in an epicardial lead system occurred 
in 1 p" and revision was required in 2 (1 SQ patch, 1 array) due to high DFTs 
prior to hospital dismissal. Complications occurred in 4 pts (1 pneumothorax, 
1 pneumonia, and 2 hematoma). There was no operative mortality. During 
flu (30 + 28 mos), 2 pts (1 in each group) died (1 from MI and 1 from breast 
CA). Four pts received appropriate si~ocks (2 in each group) and 2 recei~,ed 
inappropriate shocks (1 in each group). No high DFTs were found during 
routine follow up at 3 and 12 rods following initial implantation (10 ± 5 J and 
14 ± 6 J, respectively). 
Cpr¢~.  ICD ,mplanlatK)n , HCM pts can be m~,ornl~,lN~ w~n 
h~gh socce-- -'~te, low mod~dity and motlalily DFT~ remain stable dur~ 
Iong4em~ e-qp, APprOpriate ICD ~hock~ S~gge$1 efte¢.'hvem~ ,n both 
pnman/ar~ ~"on~p/SCD prevent,on In t~s hlgh.nsk p0~t~ 
equ I I~t  
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Induslna! wod~ env~fonrnen~ may Contort ~ ~_~ Of 
e~',omagne~ I ~  (EU~), La,~ matWe~ r~e~ can ~t  ~ 
~ nome may ~ ~ s~,  111e ~ Of ~ iltudy was 
to mvemmate Ipm~pe~y ~ ~afety of ICDs m the= ~ ,  
A4~:  I ~  were mat at ~r  w o ~  by a c l~  e ~  who 
intempgated ~ ICD, enabled the ORS ~ f  and e ~  the ¢lateclmn 
d~atmn Io 15 se¢or~s. The magnet response and 1:1 QRS ~ were 
verified. ~h ~ l  wa~,~l thmogh their work l~ and p ~  typcat 
dutNm wt~le the ICD's beebe~ continuously mof~lom¢l mmsm0 matu=. At me 
conctusmn of telling, all paramete~ were rat~.med Io their ~ vaJu4~. 
~ "  t7 pts (15 men, mean age 51 ym) w~h iCDs (CPI) ha4 WO~d.T_=~_ 
teslmg before re~rnm9 tu tbeir lob All IMI 1 I]1 had a non-thoracofomy lead 
slnltam. Only 11146 ICD ~ ~ 105 ~ Of ~ equ~ 
(including 29 contacts ~ am we~ng equipment) ~ a problem. A 
steet ~*~drer was msponsd~ I~ a.achtng a huge electromagnet to a cren~ 
used Io move large mmel coibt. ~ from his IU'~ was temporarily i ~  
wf~le m me magne~ field. 
~ :  The use of a simple soreanmg procedere can sately ~lent~fy 
sourees of EMI I1~I may affect ICD operation. How~/e~. Lndustrtal =ourcos of 
EMI rarely affect ICD fUnCtKm. Thus ICD implanl (toes not preclude working 
around in~mnal equipment 
ht -~bt  v= Out -o~i  PmmntmUon of 
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Implantable Defibril lators (AVID) Regislm/ 
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Data from the AVID re~stpf were used to dmermme whether patients (pts) 
presenting w~h out-of-hosl~al (OOH) life-threatening vantnczdar arrhylhrmas 
IVA) have o~,fferent short, and Iong-tem~ prognosm ~re  pt= presan~ng w~ 
m-hospdal (::4) VAs AVID ,s a prospective, r a ~  study companng 
the iT~ial treatment of VA ~lh an m~plantable c a ~  datibnflalor o~ an 
antiaoflylhmi¢ drug (AAD). TO be el@ble for randomtzaben, pts must have 
survived ed~r car0iac arrest due Io a VA or susl~;i-~3 ~;~;u lar  lachycardia 
(VT) ~lh hemoo~ comwom~. IH VAS were seen in 838 and OOH 
VAs in 1926 pts Pts wffh IH VAS "had higher IH mortatlty (4.7% vs 1.2%, p ~ 
0 001), and were s~cker than these wrth OOH VAs (IH/OOH): LV EF 0.30/0.34 
(p < 0001), history of (h/o) CHF 55%/40% (p < 0.001), Wo of alrtal fibdflation 
31%d22% (p < 0.001), h/o dmbetes 31%/18% (p < 0.001), Wo VT 20%/14% 
(p < 0.001), Wo s~T, cope 15%/10% (p < 0.001), I1/o CABC_dPTCA 3 ~  
(p = 0.01). presence of CAD 80%/75% (p = 0.005), and AAD mm at ;r,~,~x 
event 18%/13% (p -~ 0.001). Discharge medioatfons: dlure~c 60%/46% (p 
-: 0.001). digoxin 49~'4G% (p < 0.001), and beta blockers 24%/29% (p : 
0.007). Prior historms of VF, MI. Ogare~e use, nonlschemc cafdtomyopathy, 
and ACE and cafoum blocker use were nol s=gnifH~nlty different. The relative 
nsk (adjusted for baseline vanables) for long-term mortality in IH pts was 2.3 
compared to OOH pts (p < 0.001). 
Conclusion. P~ with IH resL.sotat:on am sfcker, have lower IH sun,,Nal, 
and greater long term mortality compared to ftmse whOSe Lrt0~_x VA occurs 
OOH. This difference in survwal remains after adlus~ng for all the measured 
baseline predictors. 
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